Retraction Note: Cellular Oncology (2021) 44:1425–1437
10.1007/s13402-021-00651-8
The Editors-in-Chief have retracted this article at the authors’ request. After publication, the authors contacted the journal requesting a correction to Figs. 4 and 5 due to image overlap with their other article, specifically:
Figure 4d 48 h IFIT1 image appears highly similar to Fig. 7f Huh7 48 h control in [1].
Figure 5c Aspc-1 si-IFIT1 image appears highly similar to Fig. 7h Huh7 si-METTL18 in [1].
Figure 5a and c Aspc-1 si-IFIT1 images appear to overlap.
Further checks by the Publisher found several additional cases of image overlap in Figs. 2, 4 and 5, as well as other similarities between Figs. 4 and 7 in this article and Fig. 7 in [1]. The authors have provided the underlying raw data for validation, but due to the high number of errors in the published figures, the authors have decided to retract this article.
The authors have been invited to resubmit a corrected version of the article for peer review.
All authors agree to this retraction.
Footnotes
The online version of the original article can be found at 10.1007/s13402-021-00651-8.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Li T-H, Qin C, Zhao B-B, Cao H-T, Yang X-Y, Wang Y-Y, Li Z-R, Zhou X-T, Wang W-B. Identification METTL18 as a potential prognosis Biomarker and Associated with Immune infiltrates in Hepatocellular Carcinoma. Front. Oncol. 2021;11:665192. doi: 10.3389/fonc.2021.665192. [DOI] [PMC free article] [PubMed] [Google Scholar]